2025/01/24 by J. Russell Stothard · 1 voice
Immunology and Microbiology · Medicine · Nursing · #Parasites and Host Interactions #Global Maternal and Child Health #Child Nutrition and Water Access
paper · pdf · doi:10.1093/inthealth/ihae094
openalex publication_date 2025/01/24 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29
It is an awkward fact that effective public health control of schistosomiasis in Africa has yet to deliver a fully comprehensive intervention for appropriate anthelmintic treatment of those preschool-age children and infants with active infection(s) and/or insidious disease. Over the last decade, despite the steady progress of the Pediatric Praziquantel Consortium in developing a monoenantiomeric oral dispersible tablet, future challenges remain in securing its deployment and implementation at scale. This commentary provides a forward-looking critique for the international community, reminding us of this unfortunate treatment gap, and seeks to encourage commensurate action on ameliorating this overlooked medical inequity.